2021 / 02

Следующая статья
DOI: 10.24075/medet.2021.017

ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ

Вакцинопрофилактика COVID-19: оценка вклада в схемах терапии и прогноза инфекции

М. К. Карташова, Я. В. Киселева, М. Ч. Семенистая, Ч. С. Павлов
Информация об авторах

Первый Московский государственный медицинский университет им. И.М. Сеченова, Москва, Россия

Автор для корреспонденции: Карташова Мария Константиновна
Трубецкая ул., д.8 стр.2, г. Москва, 119048; moc.liamg@3698kmk

Статья получена: 08.04.2021 Статья принята к печати: 15.05.2021 Опубликовано online: 14.10.2021
|
  1. ArcGIS. COVID-19 Dashboard by the Center for Systems Science and Engineeing (CSSE) at Johns Hopkins University (JHU).; 2021. [Электронныый ресурс]. Режим доступа:https://www.arcgis.com/apps/dashboards/bda7594740fd40299423467b48e9ecf6 (дата обращения: 25.07.2021).
  2. Adil MT, Rahman R, Whitelaw D, et al. SARS-CoV-2 and the pandemic of COVID-19. Postgrad Med J. 2021;97(1144):110-116. DOI: 10.1136/postgradmedj-2020-138386
  3. Ita K. Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development. Arch Med Res. 2021;52(1):15-24. DOI:10.1016/j.arcmed.2020.09.010
  4. Liu X, Liu C, Liu G, Luo W, Xia N. COVID-19: Progress in diagnostics, therapy and vaccination. Theranostics. 2020;10(17):7821-7835. DOI:10.7150/thno.47987
  5. Triggle CR, Bansal D, Farag EABA, Ding H, Sultan AA. COVID-19: Learning from Lessons To Guide Treatment and Prevention Interventions. Rosenberg HF, ed. mSphere. 2020;5(3). DOI:10.1128/mSphere.00317-20
  6. Gavriatopoulou M, Ntanasis-Stathopoulos I, Korompoki E, et al. Emerging treatment strategies for COVID-19 infection. Clin Exp Med. 2021;21(2):167-179. DOI:10.1007/s10238-020-00671-y
  7. Wang F, Kream RM, Stefano GB. Long-Term Respiratory and Neurological Sequelae of COVID-19. Med Sci Monit. 2020;26. DOI:10.12659/MSM.928996
  8. Chung JY, Thone MN, Kwon YJ. COVID-19 vaccines: The status and perspectives in delivery points of view. Adv Drug Deliv Rev. 2021;170:1-25. DOI:10.1016/j.addr.2020.12.011
  9. Alhazzani W, Møller MH, Arabi YM, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020;46(5):854-887. DOI:10.1007/s00134-020-06022-5
  10. Zhao J, Zhao S, Ou J, et al. COVID-19: Coronavirus Vaccine Development Updates. Front Immunol. 2020;11:602256. DOI:10.3389/fimmu.2020.602256
  11. Plotkin S. History of vaccination. Proc Natl Acad Sci. 2014;111(34):12283-12287. DOI:10.1073/pnas.1400472111
  12. WHO. BCG Vaccine. Data from WHO.; 2008. [Электронныый ресурс]. Режим доступа: https://www.who.int/immunization/BCG_8May2008_RU.pdf (дата обращения - 20.07.2021).
  13. World Health Organisation. Coronavirus disease (COVID-19): Vaccines. Published June 22, 2021. [Электронныый ресурс]. Режим доступа: https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccines?adgroupsurvey={adgroupsurvey}&gclid=Cj0KCQjw0K-HBhDDARIsAFJ6UGiXf1LSjnMFSnaCNgstvaWHeYguB50LJeEBSaNHqpXR1i64lwqO6AsaAodHEALw_wcB (дата обращения – 10.07.2021).
  14. Ye T, Zhong Z, García‐Sastre A, Schotsaert M, De Geest BG. Current Status of COVID‐19 (Pre)Clinical Vaccine Development. Angew Chem Int Ed. 2020;59(43):18885-18897. DOI:10.1002/anie.202008319
  15. Frederiksen LSF, Zhang Y, Foged C, Thakur A. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies. Front Immunol. 2020;11:1817. DOI:10.3389/fimmu.2020.01817
  16. Dasgupta S. A Review of Vaccine Efficacy Measures. 1(1):4.
  17. Crowcroft NS, Klein NP. A framework for research on vaccine effectiveness. Vaccine. 2018;36(48):7286-7293. DOI:10.1016/j.vaccine.2018.04.016
  18. Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020;383(27):2603-2615. DOI:10.1056/NEJMoa2034577
  19. Stern PL. Key steps in vaccine development. Ann Allergy Asthma Immunol. 2020;125(1):17-27. DOI:10.1016/j.anai.2020.01.025